Skip to main content
Log in

Cplx2 gene expression following semax or PGP administration under conditions of two experimental models of rat-brain ischemia

  • Experimental Works
  • Published:
Molecular Genetics, Microbiology and Virology Aims and scope Submit manuscript

Abstract

Complexin 2 is a cytosolic protein participating in synaptic-vesicle exocytosis. The RT-PCR technique was used in a real-time study of the dynamics of variation of expression of the Cplx2 gene that encodes this protein. The study was performed in the rat brain. Measurements under the conditions of incomplete global ischemia were performed during 1 day; measurements under the conditions of focal ischemia were carried out 3, 24, and 72 h after irreversible occlusion of the medial cerebral artery. The most significant decrease in Cplx2 transcripts under the conditions of incomplete global ischemia was observed in the hippocampus and the frontal cortex of rats 12 and 24 h after irreversible occlusion of the common carotid arteries, respectively. Under conditions of focal ischemia, a decrease in the content of Cplx2 transcripts was observed only in focal lesions of the frontoparietal cortex 24 h after occlusion. The effect of Semax neuroprotector peptide and its C-terminal fragment Pro-Gly-Pro on Cplx2 expression was examined under the model ischemia conditions. In the case of incomplete global ischemia, application of Semax compensated for the maximum decrease in Cplx2 expression in the frontal cortex and hippocampus in rats caused by lesions. However, the peptide had no effect when used in rats with focal ischemia. The effect of PGP on Cplx2 expression under conditions of experimental ischemia was more complicated and did not always coincide with the effect of Semax. The obtained results provide insight into the specific features of Cplx2 expression under the conditions of experimental brain ischemia and help to better understand the mechanisms of activity of peptide preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hofmeijer, J. and van Putten, M.J., Ischemic cerebral damage: An appraisal of synaptic failure, Stroke, 2012, vol. 43, no. 2, pp. 607–615.

    Article  PubMed  Google Scholar 

  2. Pabst, S., Hazzard, J.W., Antonin, W., Südhof, T.C., Jahn, R., Rizo, J., et al., Selective interaction of complexin with the neuronal SNARE complex. Determination of the binding regions, J. Biol. Chem., 2000, vol. 275, no. 26, pp. 19808–19818.

    Article  CAS  PubMed  Google Scholar 

  3. Neher, E., Complexin: does it deserve its name?, Neuron, 2010, vol. 68, no. 5, pp. 803–806.

    Article  CAS  PubMed  Google Scholar 

  4. Hazell, A.S. and Wang, D., Identification of complexin IIin astrocytes: A possible regulator of glutamate release in these cells, Biochem. Biophys. Res. Commun., 2011, vol. 404, no. 1, pp. 228–232.

    Article  CAS  PubMed  Google Scholar 

  5. Wang, Z., Wei, X., Liu, K., Zhang, X., Yang, F., Zhang, H., et al., NOX2 deficiency ameliorates cerebral injury through reduction of complexin II-mediated glutamate excitotoxicity in experimental stroke, Free Radical Biol. Med., 2013, vol. 65, pp. 942–951.

    Article  CAS  Google Scholar 

  6. Yakovleva, E.V., Kuzenkov, V.S., Fedorov, V.N., Skvortsova, V.I., Koshelev, V.B., Gusev, E.I., et al., In vivo efficiency of Semax in global cerebral ischemia, Bull. Exp. Biol. Med., 1999, vol. 128, no. 2, pp.806–807.

    Article  CAS  Google Scholar 

  7. Gusev, E.I., Skvortsova, V.I., Myasoedov, N.F., Nezavibat’ko, V.N., Zhuravleva, E.I., and Vanichkin, A.V., Semax efficiency in acute period of hemispheric ischemic stroke, Zh. Nevrol. Psikhiatr. im. S.S. Korsakova, 1997, vol. 97, pp. 26–34.

    CAS  PubMed  Google Scholar 

  8. Myasoedov, N.F., Skvortsova, V.I., Nasonov, E.L., Zhuravleva, E.I., Grivennikov, I.A., Arsen’eva, E.L., et al., Semax neuroprotective effect in acute period of ischemic stroke, Zh. Nevrol. Psikhiatr. im. S.S. Korsakova, 1999, vol. 99, pp. 15–19.

    Google Scholar 

  9. Alekseeva, G.V., Bottaeva, N.A., and Gorshkova, V.V., Semax usage in patients with post-hypoxic brain pathology for long-term period, Anesteziol. Reanimatol., 1999, vol. 1, pp. 40–43.

    Google Scholar 

  10. Kaplan, A.I., Koshelev, V.B., Nezavibat’ko, V.N., and Ashmarin, I.P., The way to increase an organism resistance against hypoxia with the help of neuropeptide drug Semax, Fiziol. Chel., 1992, vol. 18, no. 5, pp. 104–107.

    CAS  Google Scholar 

  11. Storozhevykh, T.P., Tukhbatova, G.R., Senilova, Ya.E., Pinelis, V.G., Andreeva, L.A., and Myasoedov, N.F., Effects of Semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity, Bull. Exp. Biol. Med., 2007, vol. 143, no. 5, pp. 601–604.

    Article  CAS  PubMed  Google Scholar 

  12. Martynova, K.V., Andreeva, L.A., Klimova, P.A., Kirillova, Yu.G., Shevchenko, V.P., Nagaev, I.Yu., et al., Structural-functional study of glycine-and-proline- containing peptides (glyprolines) as potential neuroprotectors, Russ. J. Bioorg. Chem., 2009, vol. 35, no. 2, pp. 150–156.

    Article  CAS  Google Scholar 

  13. Dmitrieva, V.G., Dergunova, L.V., Povarova, O.V., Skvortsova, V.I., Limborskaya, S.A., and Myasoedov, N.F., The effect of Semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of experimental cerebral ischemia, Dokl. Biochem. Biophys., 2008, vol. 422, pp. 261–264.

    Article  CAS  PubMed  Google Scholar 

  14. Dmitrieva, V.G., Povarova, O.V., Skvortsova, V.I., Limborska, S.A., Myasoedov, N.F., and Dergunova, L.V., Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia, Cell. Mol. Neurobiol., 2010, vol. 30, no. 1, pp. 71–79.

    Article  CAS  PubMed  Google Scholar 

  15. Stavchansky, V.V., Tvorogova, T.V., Botsina, A.Yu., Skvortsova, V.I., Limborska, S.A., Myasoedov, N.F., and Dergunova, L.V., Effect of Semax and its C-terminal peptide PGP on expression of neurotrophins and their receptors in rat brain during incomplete global ischemia, Mol. Biol. (Moscow), 2011, vol. 45, no. 6, pp. 941–949.

    Article  CAS  Google Scholar 

  16. Raevskaya, N.M., Dergunova, L.V., Vladychenskaya, I.P., Stavchansky, V.V., Oborina, M.V., Poltaraus, A.B., et al., Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity, Gene, 2005, vol. 359, pp. 127–137.

    Article  CAS  PubMed  Google Scholar 

  17. Dmitrieva, V.G., Torshina, E.V., Yuzhakov, V.V., Povarovac, O.V., Skvortsova, V.I., Limborska, S.A., et al., Expression of sphingomyelin synthase 1 gene in rat brain focal ischemia, Brain Res., 2008, vol. 1188, pp. 222–227.

    Article  CAS  PubMed  Google Scholar 

  18. Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res., 2001, vol. 29, no. 9, pp. 2002–2007.

    Article  Google Scholar 

  19. Pfaffl, M.W., Horgan, G.W., and Dempfle, L., Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR, Nucleic Acids Res., 2002, vol. 30, no. 9, p. e36.

    Article  Google Scholar 

  20. Sieber, F.E., Palmon, S.C., Traystman, R.J., and Martin, L.J., Global incomplete cerebral ischemia produces predominantly cortical neuronal injury, Stroke, 1995, vol. 26, pp. 2091–2096.

    Article  CAS  PubMed  Google Scholar 

  21. Stavchansky, V.V., Yuzhakov, V.V., Botsina, A.Y., Skvortsova, V.I., Bondurko, L.N., Tsyganova, M.G., et al., The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study, J. Mol. Neurosci., 2011, vol. 45, no. 2, pp. 177–185.

    Article  CAS  PubMed  Google Scholar 

  22. Astashkin, E.I., Bespalova, Yu.B., Grivennikov, I.A., Smirnov, O.N., Glezer, M.G., Grachev, S.V., and Myasoedov, N.F., Effects of Semax on Ca2+ responses of human neutrophils, Dokl. Biol. Sci., 2000, vol. 374, pp. 536–538.

    CAS  PubMed  Google Scholar 

  23. Bashkatova, V.G., Koshelev, V.B., Fadyukova, O.E., Alexeev, A.A., Vanin, A.F., Rayevsky, K.S., Ashmarin, I.P., and Armstrong, D.M., Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia, Brain Res., 2001, vol. 894, pp. 145–149.

    Article  CAS  PubMed  Google Scholar 

  24. Medvedeva, E.V., Dmitrieva, V.G., Povarova, O.V., Limborska, S.A., Skvortsova, V.I., Myasoedov, N.F., et al., The peptide Semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis, BMC Genomics, 2014, vol. 15, p. 228. http://www.biomedcentral.com/1471-2164/15/228.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. V. Stavchansky.

Additional information

Original Russian Text © V.V. Stavchansky, E.O. Kurichenkova, V.G. Dmitrieva, N.F. Myasoedov, S.A. Limborska, L.V. Dergunova, 2016, published in Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya, 2016, No. 4, pp. 137–142.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stavchansky, V.V., Kurichenkova, E.O., Dmitrieva, V.G. et al. Cplx2 gene expression following semax or PGP administration under conditions of two experimental models of rat-brain ischemia. Mol. Genet. Microbiol. Virol. 31, 214–219 (2016). https://doi.org/10.3103/S0891416816040078

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0891416816040078

Keywords

Navigation